Strategic Blueprint
LLY icon

Strategic Blueprint’s Eli Lilly LLY Stock Holding History

Strategic Blueprint’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.9M Sell
12,911
-785
-6% -$926K 0.73% 27
2026
Q2 		$16.4M Buy
13,696
+1,430
+12% +$1.46M 0.82% 22
2026
Q1 		$11.3M Buy
12,266
+124
+1% +$126K 0.66% 31
2025
Q4 		$13M Sell
12,142
-2,083
-15% -$1.99M 0.77% 24
2025
Q3 		$10.9M Sell
14,225
-110
-0.8% -$81.9K 0.47% 48
2025
Q2 		$11.2M Buy
14,335
+1,485
+12% +$1.15M 0.55% 40
2025
Q1 		$10.6M Buy
12,850
+1,304
+11% +$1.09M 0.58% 39
2024
Q4 		$8.91M Sell
11,546
-17
-0.1% -$14.1K 0.53% 43
2024
Q3 		$10.2M Sell
11,563
-463
-4% -$416K 0.64% 33
2024
Q2 		$10.9M Sell
12,026
-131
-1% -$105K 0.74% 28
2024
Q1 		$9.46M Sell
12,157
-43
-0.4% -$30.6K 0.67% 32
2023
Q4 		$7.11M Buy
12,200
+89
+0.7% +$51.9K 0.59% 37
2023
Q3 		$6.51M Sell
12,111
-271
-2% -$140K 0.6% 37
2023
Q2 		$5.81M Buy
12,382
+7,103
+135% +$2.98M 0.55% 38
2023
Q1 		$1.81M Buy
5,279
+576
+12% +$194K 0.19% 123
2022
Q4 		$1.72M Sell
4,703
-523
-10% -$185K 0.2% 124
2022
Q3 		$1.69M Buy
5,226
+53
+1% +$16.8K 0.2% 119
2022
Q2 		$1.68M Buy
5,173
+625
+14% +$188K 0.21% 122
2022
Q1 		$1.3M Buy
4,548
+240
+6% +$61.8K 0.15% 142
2021
Q4 		$1.19M Buy
4,308
+1,312
+44% +$333K 0.15% 154
2021
Q3 		$692K Buy
2,996
+131
+5% +$32.3K 0.11% 189
2021
Q2 		$658K Buy
2,865
+225
+9% +$45.2K 0.1% 197
2021
Q1 		$493K Sell
2,640
-245
-8% -$47.9K 0.1% 172
2020
Q4 		$487K Buy
2,885
+287
+11% +$42.9K 0.12% 142
2020
Q3 		$385K Buy
2,598
+545
+27% +$84.3K 0.12% 143
2020
Q2 		$337K Buy
+2,053
New +$315K 0.12% 118

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Strategic Blueprint's LLY Position: Q3 2026 in Review

Strategic Blueprint reduced its Eli Lilly (LLY) stake by 5.7% in Q3 2026, selling an estimated $926K and leaving 12,911 shares worth $14.9M. The position accounts for 0.73% of the portfolio, ranked #27.

Strategic Blueprint first reported a position in LLY in Q2 2020 and has held it in 26 quarters since. The position peaked at $16.4M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Strategic Blueprint held 12,911 shares of Eli Lilly worth $14.9M as of Q3 2026.
  • Strategic Blueprint sold 785 Eli Lilly shares in Q3 2026, an estimated $926K.
  • Eli Lilly made up 0.73% of Strategic Blueprint's portfolio in Q3 2026, its #27 holding.
  • Strategic Blueprint first reported a position in Eli Lilly in Q2 2020 and has held it in 26 quarters since.
  • Strategic Blueprint's Eli Lilly position peaked at $16.4M in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Strategic Blueprint's 13F filing for Q3 2026, filed 22 Oct 2026.